Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05175625
What this trial is testing

Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine

Who this might be right for
COVID-19
Cinnagen 300
Very early researchUnknownNCT06259578
What this trial is testing

UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)

Who this might be right for
COVID-19 PandemicCOVID-19 VaccinesCOVID-19 Virus Disease
Dr. Soetomo General Hospital 400
Large-scale testing (Phase 3)WithdrawnNCT05534048
What this trial is testing

Booster Study of PTX-COVID19-B in Adults Aged 18 Years and Older

Who this might be right for
SARS-CoV-2 Infection
Everest Medicines (Singapore) Pte. Ltd.
Not applicableStudy completedNCT05367908
What this trial is testing

Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 1,501
Testing effectiveness (Phase 2)Temporarily pausedNCT05150496
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 640
Testing effectiveness (Phase 2)Study completedNCT05605470
What this trial is testing

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Who this might be right for
COVID-19, SARS CoV 2 Infection
Technovalia, Pty Ltd 150
Not applicableUnknownNCT05125874
What this trial is testing

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 45
Early research (Phase 1)Study completedNCT06441968
What this trial is testing

Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)Study completedNCT06436911
What this trial is testing

To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA

Who this might be right for
COVID-19
Entos Pharmaceuticals Inc. 46
Large-scale testing (Phase 3)Study completedNCT05567471
What this trial is testing

Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose

Who this might be right for
COVID-19 Respiratory Infection
Bharat Biotech International Limited 875
Not applicableUnknownNCT05289206
What this trial is testing

Immune Response of an Interchangeable Booster Vaccine Against COVID-19 Among Individuals With Risk Factors for Severity

Who this might be right for
Comorbidities and Coexisting ConditionsHealthy
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 4,446
Testing effectiveness (Phase 2)Study completedNCT05198063
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Early research (Phase 1)Study completedNCT04569383
What this trial is testing

Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf 30
Testing effectiveness (Phase 2)UnknownNCT05330871
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.

Who this might be right for
COVID-19
Seventh Medical Center of PLA General Hospital 410
Not applicableStudy completedNCT05233592
What this trial is testing

Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes

Who this might be right for
Type 1 DiabetesDiabetes Mellitus, Type 1
Johns Hopkins University 21
Post-approval studies (Phase 4)Study completedNCT05165966
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 340
Testing effectiveness (Phase 2)Study completedNCT05960097
What this trial is testing

A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2COVID-19
GlaxoSmithKline 692
Post-approval studies (Phase 4)Study completedNCT06065176
What this trial is testing

The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

Who this might be right for
COVID-19Vaccine-Preventable DiseasesSARS CoV 2 Infection+2 more
Sarang K. Yoon, DO, MOH 1,188
Testing effectiveness (Phase 2)Looking for participantsNCT06599658
What this trial is testing

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Who this might be right for
COVID 19InfluenzaRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 660
Very early researchEnded earlyNCT05081271
What this trial is testing

COVID-19 Booster Vaccination in Persons With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Griffin Hospital 10
Next Page